Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats

Rejuvenation Research

Volumn 16, Issue 2, 2013, Pages 124-133

  Zeng, Gao Feng ^a   Zhang, Zhi Yong ^a   Lu, Li ^a   Xiao, De Qiang ^a   Zong, Shao Hui ^b   He, Jian Ming ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GINGER EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN; BRAIN METABOLISM; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; BEHAVIOR, ANIMAL; CATALASE; FEMALE; GINGER; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; SUPEROXIDE DISMUTASE;

RATTUS; ZINGIBER OFFICINALE;

EID: 84876584371     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2012.1389     Document Type: Article

References (56)

1. Yu Y, Zick S, Li X, Zou P, Wright B, Sun D. Examination of the pharmacokinetics of active ingredients of ginger in humans. Am Assoc Pharmaceut Sci J 2011;13:417-426.
2. Sun Y-j. Progress of ginger in pharmacological research. Modern J Integrated Tradit Chinese Western Med 2007;16:561-564.
3. Wang J, Zhang W, Wang Y-s, Liu H-x, Huang Q-f. Protective effect of ginger extract on cerebral ischemia-reperfusion injury. Clin J Tradit Chinese Med 2007;19:23-24.
4. Cheng X. Overview of the traditional prescription on treatment of insomnia. Henan Tradit Chinese Med 2005;25:82-83.
5. Li S-m. The effect of Chaihulonggumuli soup on treatment of neuropsychiatric diseases. Henan J Tradit Chinese Med 2001;16:34-35.
6. Nan J-s, Li X-l, Chang D. Da Chang's experience of using Chaihulonggumuli soup on treatment of neuropsychiatric diseases. J Practical Tradit Chinese Med 1998;14:36-37.
7. Yan H-Y, Zhang H-M, Qiao X-J. Inhibited effect of ginger and garlic on reactive oxygen species. J BaoTou Med Coll 1997;13:10212.
8. Ghayur MN, Gilani AH, Ahmed T, Khalid A, Nawaz SA, Agbedahunsi JM, Choudhary MI, Houghton PJ. Muscarinic, Ca( + + ) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 2008;60:1375-1383.
9. Wang Q, Song X-Y, Zhu Y. Effect of ginger alcohol extract on antioxidant and anti-hypoxia. China J Chinese Mater Med 2003;28:551-552.
10. Song X-Y, Wang Q, Zhu Y. Protective effect of ginger on acute hypoxic mice. J Capital University Med Sci 2004;25:438-440.
11. 2+-ATPase activity and the impact of lactic acid in the ischemic brain injury[J]. Med Theory Pract 1999;12:7-9.
12. Wang J, Zhang L, Wang Z-H. Effect of ginger extract on ATP enzyme and metabolism of free radicals in mouse brain tissue of cerebral ischemia and reperfusion injury. Jiangsu Tradit Chinese Med 2007;39:59-80.
13. Wang J, Zhang W, Wang Y-S. The protective effect of aqueous extract of ginger on cerebral ischemia-reperfusion injury. Clin J Tradit Chinese Med 2007;19:23-24.
14. Wang J, Huang Q-F, Jia S-Q. Effect of aqueous extract of ginger on vascular dementia in rats. Lab Pharmacol 2008;37:33-37.
15. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Alternative Complementary Med 2004;10:1009-1013.
16. Shim S, Kim S, Kwon Y-B, Kwon J. Protection by [6]-shogaol against lipopolysaccharide-induced toxicity in murine as-trocytes is related to production of brain-derived neuro-trophic factor. Food Chem Toxicol 2012;50:597-602.
17. Hanish Singh JC, Alagarsamy V, Diwan PV, Sathesh Kumar S, Nisha JC, Narsimha Reddy Y. Neuroprotective effect of Alpinia galanga (L.) fractions on Ab(25-35) induced amnesia in mice. J Ethnopharmacol 2011;138:85-91.
18. Salminen A, Ojala J, Kauppinen A, Kaarniranta KAI, Suur-onen T. Inflammation in immunity defencce via pattern recognition receptors. Prog Neurobiol 2009;87:181-194.
19. Buckingham SD, Jones AK, Brown LA, Sattlelle DB. Nico-tinic aacetycholine receptor signalling: Roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 2009;61:39-61.
20. Jakob-Roetne R, Jacobsen H. Alzheimer's disease: From pathology to therapeutic approaches. Angew Chem Int Ed Engl 2009;48:3030-3059.
21. Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 2009;8:16-30.
22. Lovell MA. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis 2009;16:471-483.
23. Goedert M, Spillantini MG. A century of A1zheimer's disease. Science 2006;314:777-781.
24. Ji HF, Zhang HY. Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural festures. Acta Pharmacologica Sinica 2008;29:143-151.
25. Zhu X-Z, Li X-Y, Li J. Recent pharmacological studies on natural products in China. Eur J Pharmacol 2004;500:221-223.
26. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phyto-chemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 2008;46:409-420.
27. Wang F, Huang Y-a, Lu J. The test of acute toxicity on different ginger extract. Food Res Dev 2009;30:138-140.
28. Liu Z-a, Zhao W-w, Ma K, Lu C-e, Xu T-j. Establishment of a Alzheimer's disease rat model intervened by beta-amyloid protein 1-40 and aluminum chloride. J Clin Rehabil Tiss Eng Res 2010;14:6917-6921.
29. Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 1996;35:4287-4297.
30. Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci 2004;61:192-208.
31. Gilmore TD. Introduction to NF-jB: Players, pathways, perspectives. Oncogene 2006;25:6680-6884.
32. DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's cancer: Principles & Practice of Oncology. Lip-pincott Williams & Wilkins, Philadelphia, 2008.
33. Nair V, O'Neil CL, Wang PG. Malondialdehyde. In: Encyclopedia of Reagents for Organic Synthesis. John Wiley & Sons, New York, 2008.
34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4th ed. Elsevier Science & Technology Press, New York, 2004.
35. Liu H, Yuan J, Li Y, Wang Y. Ethanol extract of Zingiber officinale Rose induces cell apoptosis and inhibits cell proliferation in mice with HepA liver cancer. Guangdong Med J 2011;32:969-970.
36. Wang L-s, Zhou J, Shao X-m, Tang X-c. Huperzine A attenuates cognitive deficits and brain injury after hypoxic-ischemic brain damage in neonatal rats. Chinese J Pediatr 2003;41:42-45.
37. Kumar A, Seghal N, Naidu PS, Padi SS, Goyal R. Colehicine-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type. Pharmacol Rep 2007;59:274-283.
38. Bavaresco CS, Streck EL, Netto CA, Wyse AT. Chronic hy-perprolinemia provokes a memory deficit in the Morris water maze task. Metab Brain Dis 2005; 20: 73-80.
39. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12:1606-1614.
40. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Mieretubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986;261:6084-6089.
41. Glermer GG, Wong CW. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Bioehem Biophys Res Commun 1984;122:1131-1135.
42. Cottrell DA, Blakely EL, Johnson MA, Ince PG, Turnbull DM. Mitochondral enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 2001;57:260.
43. Duyckaerts C, Potier MC, Delatour B. Alzheimer disease models and human neuropathology: Similarities and differences. Acta Neuropathol 2008;115:5-38.
44. Rodella LF, Ricci F, Borsani E, Stacchiotti A, Foglio E, Favero G, Rezzani R, Mariani C, Bianchi R. Aluminium exposure induces AIzheimer's disease-like histopathological alterations in mouse brain. Histol Histopathol 2008;23:433-439.
45. Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, Ra-vid R, Shankar SK, Stein R, Shanmugavelu P, Jagannatha Rao KS. Aluminium in Alzheimer's disease: Are we still at a crossroad? Cell Mol Life Sci 2005;62:143-158.
46. Christian B. Alzheimer's disease and oxidative stress: Implication for novel therapeutic approaches. Progr Neurobiol 1999;57:301.
47. Coleman PD, Yao PJ. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 2003;24:1023-1027.
48. Ghayur MN, Khan AH, Gilani AH. Ginger facilitates cho-linergic activity possibly due to blockade of muscarinic au-toreceptors in rat stomach fundus. Pak J Pharm Sci 2007;20:231-235.
49. Bonini JS, Da Silva WC, Bevilaqua LR, Medina JH, Izquierdo I, Cammarota M. On the participation of hippocampal PKC in acquisition, consolidation and reconsolidation of spatial memory. Neuroscience 2007;147:37-45.
50. Tang Y, Yu SG, Luo S, Han T, Yin HY. Neuroprotective effect of electroacupuncture therapy on damaged cholinergic neurons in rats with Alzheimer's disease. Chin Integr Med 2006;4:374-376.
51. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71:621-629.
52. de la Monte SM, Neely TR, Cannon J, Wands JR. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 2000;57:1471-1481.
53. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46:705.
54. Baldwin AS. The NF-kB and I-kB proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-681.
55. Bales KR, Du Y, Dodel RC, Yan GM, Hamilton-Byrd E, Paul SM. The NF-kB/Rel family of proteins mediates A beta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 1998;57:63-72.
56. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.